Teva Colrefuz 500 mikrog

Colrefuz is a pharmaceutical product containing colchicine, primarily used for the treatment and prevention of gout attacks. The medication is marketed and distributed by Teva Pharmaceutical Industries Ltd., one of the world's largest generic drug manufacturers.

As a global pharmaceutical giant, Teva operates a vast network of manufacturing facilities across Europe, North America, and Asia. While the brand originates from Israel, the specific batch of a product like Colrefuz is typically manufactured in one of Teva's many international production sites tailored for the European and Scandinavian markets. The packaging shown features Swedish and Finnish text ("tabletter/tabletit"), indicating it is intended for the Nordic region.

Teva's global dominance in the generics market ensures that products like Colrefuz are produced under strict international quality standards. The ultimate ownership remains with the Israeli parent company, which oversees a complex web of subsidiaries that facilitate local distribution and regulatory compliance in nearly every major global market.